SURREY, BC / ACCESSWIRE / January 30, 2017 / DESERT GOLD VENTURES INC. (TSX-V: DAU) (FSE: QXR2) (OTC PINK: DAUGF) (“Desert Gold” or the “Company”) announces that it held its extraordinary meeting on January 5, 2017 (the “Meeting”). At the Meeting, shareholders approved the termination of the Company’s 2012 Fixed Option Plan and the implementation of a 10% rolling Option Plan in its place, which is subject to approval by the Toronto Venture Stock Exchange.

Shareholders also approved a grant of 258,880 excess stock options to directors and officers, exercisable at $0.30 until October 24, 2018, which were granted under the Company’s said terminated fixed option plan in late 2016. The Company has granted a further aggregate of 260,509 stock options to its directors and officers pursuant to its new 10% rolling Option Plan, exercisable at $0.30 for a period of five (5) years from today.

The Company is pleased to announce that Mr. Scharf, currently a director of the board, will now assume the position of President of the Company effective immediately.

ON BEHALF OF THE BOARD

s/ “Jared Scharf”
Jared Scharf, Director
+1 (604) 245 6802

For further information, please visit our website www.desertgold.ca, or see the information available on www.SEDAR.com under the company’s profile.

Certain statements contained in this release may constitute “forward-looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could,” “intend,” “expect,” “believe,” “will,” “projected,” “estimated,” “anticipates,” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing, and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein in the united states. The securities described herein have not been and will not be registered under the united states securities act of 1933, as amended, and may not be offered or sold in the united states or to the account or benefit of a U.S. person absent an exemption from the registration requirements of such act.

SOURCE: Desert Gold Ventures, Inc.

ReleaseID: 453887

IRVINE, CA / ACCESSWIRE / January 30, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Vista Outdoor, Inc. (“Vista” or the “Company”) (NYSE: VSTO). Investors, who purchased or otherwise acquired Vista shares between August 11, 2016, and January 13, 2017, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff deadline.

If you purchased shares of Vista during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On January 12, 2017, Vista revealed that it expects a material asset impairment charge (approximately $400 – $450 million) due to its Hunting and Shooting Accessories reporting unit during the third quarter of the 2017 fiscal year. When this news was announced, the value of Vista fell over 21% that day. On January 13, 2017, Vista stated that the President of its Outdoor Products segment, in which the Hunting and Shooting Accessories unit belongs, had left his position.

When this information was revealed to the investing public, the value of Vista declined, causing investors serious harm.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 453877

LOS ANGELES, CA / ACCESSWIRE / January 30, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against The Western Union Company (“Western Union” or the “Company”) (NYSE: WU). Investors, who purchased or otherwise acquired Western Union securities on the open market between February 24, 2012 and January 19, 2017, both dates inclusive (the “Class Period”), are advised to contact the firm prior to the March 27, 2017 lead plaintiff deadline.

To participate in this class action lawsuit, click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On January 19, 2017, the U.S. Department of Justice and the Federal Trade Commission disclosed that Western Union admitted to “aiding and abetting wire fraud” by allowing illicit money transfers to benefit human traffickers, money laundering schemes, and otherwise enable the transfer of “dirty money.”

Western Union also admitted agents were covering money laundering transactions to avoid getting caught. The Company has agreed on a $586 million settlement.

When this information was disclosed to the investing public, the value of Western Union stock fell sharply, causing investors critical harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 453876

LOS ANGELES, CA / ACCESSWIRE / January 30, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) (NASDAQ: TGTX). Investors, who purchased or otherwise acquired TG Therapeutics shares between September 15, 2014 and October 12, 2016 inclusive (the “Class Period”), are encouraged to contact the firm 60 days within this notice, also known as the lead plaintiff motion deadline.

To participate in this class action lawsuit, call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

TG Therapeutics is a biopharmaceutical company that manufactures, develops, and markets new treatments for B-cell, malignancies, and autoimmune diseases within the United Stated. The Company produces two treatments against hematological malignancies and autoimmune diseases, TG-1101 and TGR-1202. The Complaint suggests that on September 17, 2015, TG Therapeutics announced that the U.S. Food and Drug Administration (FDA) had contacted them due to a Special Protocol Assessment on the make of a Phase 3 clinical trial for TG-1101 and TGR-1202.

This Phase 3 trial, the GENUINE trial, was to demonstrate that TG-1101 could demonstrate a surge in the overall response rate and progression-free survival (“PFS”) in 330 existing patients with certain cancer cell mutations. As per the Complaint, TG Therapeutics officials failed to disclose important information regarding the Phase 3 trial, instead informing shareholders that it is the “best-in-class” treatment, “successful”, and “a novel chemo-free treatment option.” Furthermore, TG Therapeutics did not put forth an adequate screening mechanism in the GENUINE enrolling sites and did not enroll patients at the required rate for the study to be successful. Lastly, the trial did not attract 330 patients, contrary to the Company’s statements.

On October 13, 2016, TG Therapeutics put out a statement revealing that it had put out an amended GENUINE Phase 3 trial protocol with the FDA. The same day, TheStreet released an article suggesting that TG Therapeutics has a long history of poor management. The article also showed that the Company halted enrollment for the GENUINE trial by a third, removed important efficacy endpoints, and generally exposed the company to more risk. When this information was revealed to the investing public, TG Therapeutics’ stock declined almost 27%, causing investors severe harm.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

https://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 453875

LOS ANGELES, CA / ACCESSWIRE / January 30, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Illumina, Inc. (“Illumina” or the “Company”) NASDAQ: ILMN). Investors, who purchased or otherwise acquired shares between July 26, 2016 and October 10, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the February 15, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that during the Class Period, Illumina made materially false and misleading statements regarding the Company’s business, operations, and prospects. In particular, Illumina made false and/or misleading statements and failed to disclose: that the Company was experiencing a sharp decrease in sequencing instrument sales; that the decline had a significant impact on the Company’s revenue; that the Company did not have visibility into trends that could have an impact on the Company’s financial outcomes; that, as such, the Company’s revenue guidance was unreliable and exaggerated; and that, as a result of the above, Illumina’s statements about the Company’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When this information was revealed to the investing public, the value of Illumina dropped, causing investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 453872

LOS ANGELES, CA / ACCESSWIRE / January 30, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Universal Health Services, Inc. (“Universal Health” or the “Company”) (NYSE: UHS). Investors, who purchased or otherwise acquired Universal Health shares between February 26, 2015 and December 7, 2016 inclusive (the “Class Period”), are encouraged to contact the firm prior to the February 21, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On December 7, 2016, Buzzfeed issued a report revealing an extensive investigation into Universal Health, “…based on interviews with 175 current and former UHS staff, including 18 executives who ran UHS hospitals; more than 120 additional interviews with patients, government investigators, and other experts; and a cache of internal documents.”

The report noted that “[c]urrent and former employees from at least 10 UHS hospitals in nine states said they were under pressure to fill beds by almost any method – which sometimes meant exaggerating people’s symptoms or twisting their words to make them seem suicidal – and to hold them until their insurance payments ran out.”

When this information was disclosed to the public, shares of Universal Health fell nearly 12% on December 7, 2016, causing investors severe harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

https://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 453874

Webinar on Tuesday, January 31, 2017 at 11:00am EST

NEW YORK, NY / ACCESSWIRE / January 30, 2017 / PCG Advisory Group, a New York-based leading investor and public relations firm, today announced that Founder and CEO, Jeff Ramson, will present a webinar in conjunction with OTC Markets Group Inc. titled, “Social Media Strategies for Reaching Investors.” The webinar will be held on Tuesday, January 31, 2017 at 11:00am EST.

“Having an active social media presence and managing digital assets have become increasingly important for emerging growth companies vying for investor attention,” said Jeff Ramson, Founder and CEO of PCG Advisory Group. “As an early proponent of digital communications and social media marketing for maximizing investor relations strategies, I’m pleased to have the opportunity to share my experience on the best practices for reaching investors through social media, including how to build an online audience and targeting shareholders and influencers.”

“OTC Markets Group continually seeks to provide its issuers premium value-added services,” stated Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “We look forward to the webinar with Jeff and learning more about his vision on how to utilize social media to reach investors.”

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed.

About PCG Advisory Group

Founded in 2008, PCG Advisory Group is dedicated to the delivery of top tier capital markets advisory services, strategic and tactical digital and social media communications, and cutting edge media and public relations for public and privately held companies.

The team at PCG has extensive experience with life sciences and healthcare, high technology, metals and mining, financial services, and emerging growth companies from around the globe.

PCG’s Capital Markets Advisory Services include overall investor strategy development to increase and leverage investor awareness, visibility, and credibility. PCG’s Social and Digital Media services include leveraging social and professional digital media sites to effectively and accurately communicate client stories. As an aggregation, distribution, and engagement platform, PCG reaches thousands of individual, retail, and institutional investors using proprietary techniques, search engine optimization, online marketing, website development, and our proprietary and extensive distribution network. PCG’s Media and Public Relations services are a strategic and integral component of all Corporate Communications. The media and public relations team works with print, broadcast, online news sites, and bloggers to communicate the best client story at the right time. PCG also has the capabilities to support and assist a company during a merger, acquisition, or crisis. PCG’s ability to communicate the client’s story accurately and effectively is tantamount to maximizing exposure to its current and potential stakeholders (www.pcgadvisory.com).

Contacts:

Kirin M. Smith
Ksmith@pcgadvisory.com
Chief Operating Officer
D: 646.863.6519
E: Ksmith@pcgadvisory.com

SOURCE: PCG Advisory Group

ReleaseID: 453868